According to the report, the Smart Pill Technologies Market size in Europe was worth USD 811 Million in 2019 and is projected to reach USD 1795 Million by 2024, growing at a CAGR of 17.0% during the forecast period from 2019 to 2024.
Smart pill technology is used to diagnose gastrointestinal disorders such as gastroparesis and constipation. The primary function of the system includes medication recording for the patient, with information pertaining to various parameters such as pressure, temperature, and pH of gastrointestinal facts. The technology is expected to improve outcomes and workflow and decrease hospital readmissions.
The market for Smart Pill Technologies is mainly driven due to the increased prevalence of gastrointestinal diseases, sedentary lifestyle and high patient compliance on account of minimally invasive techniques. The advent of novel technologies such as catheter-less pH monitoring, ingestible sensors, and wireless capsule-based GI monitoring would raise an accelerated market growth. But, the market growth can be restrained due to possible health risks associated with a smart pill inserted into the body, privacy issues, and ethical concerns.
Europe Smart Pill Technologies Market segmented and sub-segmented into the following categories.
On the Basis of Application, the Capsule endoscopy segment is expected to be one of the largest markets owing to the advantages attached such as disease diagnosis in the small intestine. The drug delivery market is also expected to experience growth due to the benefit of improving medication efficiencies, improving patient compliance & convenience, and fast-paced technology.
On the Basis of Region, Europe is the second biggest market in terms of market share across the globe. The market in Europe is highly driven due to advanced healthcare infrastructure, increasing awareness about GI diseases among patient and physician, high adoption of technological developments, the growing geriatric population which is creating a wide range of opportunities for market players.
Top Companies dominating the Europe Smart Pill Technologies Market Profiled in the Report are CapsoVision, Inc., Given Imaging, Inc., Medimetrics S.A. de C.V., Olympus Corporation, Bio-Images Research Limited, Novartis, Given Imaging Ltd, Philips Healthcare, Smartpill, Inc., Medtronic, Inc., Pentax Medical Company, Siemens Healthcare, Stryker Corporation, GE Healthcare, Boston Scientific Corporation, IntroMedic Inc., Chongqing Jinshan Science & Technology Group Co. Ltd., Proteus Digital Health Inc.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1.2 Capsule Endoscopy
220.127.116.11 Small Bowel Video Capsule Endoscopy
18.104.22.168 Colon Capsule Endoscopy
22.214.171.124 OMOM Capsule Endoscopy Platform
126.96.36.199 Upgraded MiroCam and Advanced Capsule Endoscope
188.8.131.52 The ANKON MCE System
5.1.3 Drug Delivery
5.1.4 Patient monitoring
5.1.5 Y-o-Y Growth Analysis, By Application
5.1.6 Market Attractiveness Analysis, By Application
5.1.7 Market Share Analysis, By Application
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
184.108.40.206 By Geographical Area
220.127.116.11 By Application
6.1.4 Market Attractiveness Analysis
18.104.22.168 By Geographical Area
22.214.171.124 By Application
6.1.5 Market Share Analysis
126.96.36.199 By Geographical Area
188.8.131.52 By Application
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 CapsoVision, Inc.
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Given Imaging, Inc.
8.3 Medimetrics S.A. de C.V.
8.4 Olympus Corporation
8.5 Bio-Images Research Limited
8.7 Given Imaging Ltd
8.8 Philips Healthcare
8.9 Smartpill, Inc.
8.10 Medtronic, Inc.
8.11 Pentax Medical Company
8.12 Siemens Healthcare
8.13 Stryker Corporation
8.14 GE Healthcare
8.15 Boston Scientific Corporation
8.16 IntroMedic Inc.
8.17 Chongqing Jinshan Science & Technology Group Co. Ltd.
8.18 Proteus Digital Health Inc.
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures